Evidence map›Paper›PMID 24858344›Full record

ArticlePloS one2014

Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line.

Usawadee Dier, Dong-Hui Shin, L P Madhubhani P Hemachandra, Larissa M Uusitalo, Nadine Hempel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Subcellular Stress Markers in Epithelial Ovarian Cancer.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Interplay between altered metabolism and DNA damage and repair in ovarian cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  17. Article
  18. Alternative splice variants of the mitochondrial fission proteinbioRxiv : the preprint server for biology · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Usawadee DierNanobioscience Constellation, College of Nanoscale Science and Engineering, State University of New York, Albany, New York, United States of America.
Dong-Hui ShinNanobioscience Constellation, College of Nanoscale Science and Engineering, State University of New York, Albany, New York, United States of America.
L P Madhubhani P HemachandraNanobioscience Constellation, College of Nanoscale Science and Engineering, State University of New York, Albany, New York, United States of America.
Larissa M UusitaloNanobioscience Constellation, College of Nanoscale Science and Engineering, State University of New York, Albany, New York, United States of America.
Nadine HempelNanobioscience Constellation, College of Nanoscale Science and Engineering, State University of New York, Albany, New York, United States of America.
University at Albany, State University of New York · US

Funding

Mitochondrial Redox Control of MetastasisR00CA143229 · NCI · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI HEMPEL, NADINE · 2012 to 2014
$709k
NCI NIH HHS R00 CA143229NCI NIH HHS R00CA143229
6 · The paper itself

Abstract

Epithelial ovarian cancer (EOC) is the most lethal of all gynecological cancers, and encompasses distinct histological subtypes that have specific genetic and tissues-of-origin differences. Ovarian clear cell carcinoma (OCCC) represents approximately 10% of cases and has been termed a stress responsive cancer. OCCC is characterized by increased expression of oxidative stress and glycolysis-related genes. In the present study, we hypothesized that bioenergetic profiling might uniquely distinguish OCCC from other EOC histological subtypes. Using an extracellular flux analyzer, OCCC lines (ES-2, TOV-21-G) were shown to be highly metabolically active, with high oxygen consumption rate (OCR) and high extracellular acidification rate (ECAR), indicative of enhanced mitochondrial oxidative phosphorylation and glycolytic rate, respectively. A high bioenergetics profile was associated with the cell lines' ability to form anchorage independent spheroids. Given their high glycolytic and mitochondrial activity, OCCC cells displayed strong sensitivity to 2-deoxy-D-glucose and Rotenone growth inhibition, although this chemosensitivity profile was not specific to only OCCC cells. Bioenergetic profiling also identified a non-OCCC cell line, OVCA420, to have severely compromised mitochondrial function, based on low OCR and a lack of stimulation of maximal respiration following application of the uncoupler FCCP. This was accompanied by mitochondrial morphology changes indicative of enhanced fission, increased expression of the mitochondrial fission protein Drp1, a loss of mitochondrial membrane potential and dependence on glycolysis. Importantly, this loss of mitochondrial function was accompanied by the inability of OVCA420 cells to cope with hypoxic stress, and a compromised ability to stabilize HIF-1α in response to 1% O2 hypoxia. This knowledge may be imperative for researchers planning to utilize this cell line for further studies of metabolism and hypoxia, and suggests that altered mitochondrial fission dynamics represents a phenotype of a subpopulation of EOCs.

Indexed as

GlycolysisMembrane Potential, MitochondrialMitochondrial DynamicsOxygen ConsumptionCarbonyl Cyanide p-TrifluoromethoxyphenylhydrazoneCell HypoxiaCell Line, TumorFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitMitochondriaNeoplasm ProteinsOvarian NeoplasmsProton IonophoresCarbonyl Cyanide p-TrifluoromethoxyphenylhydrazoneHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNeoplasm ProteinsProton Ionophores

Identifiers

PMID24858344
PMCPMC4032324
OpenAlexW2053248895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.